510(k) K912026
K912026 is an FDA 510(k) premarket notification submitted by Pharmacia Diagnostics, Inc. for the device "DELFIA(R) 17 -OH-PROGESTERON KIT". The FDA issued a decision of Substantially Equivalent on June 25, 1991. The device falls under product code JLX (Radioimmunoassay, 17-Hydroxyprogesterone), a Class I device regulated under 21 CFR 862.1395. Pharmacia Diagnostics, Inc. has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 25, 1991
- Date Received
- May 7, 1991
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, 17-Hydroxyprogesterone
- Device Class
- Class I
- Regulation Number
- 862.1395
- Review Panel
- CH
- Submission Type